Cargando…

Disease Entities in Mucormycosis

Mucormycosis is an emerging life-threatening fungal infection caused by Mucorales. This infection occurs mainly in immunocompromised patients, especially with hematological malignancy, transplantation, or diabetes mellitus. Rhino-orbito-cerebral and pulmonary mucormycosis are the predominant forms....

Descripción completa

Detalles Bibliográficos
Autores principales:	Serris, Alexandra, Danion, François, Lanternier, Fanny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462957/ https://www.ncbi.nlm.nih.gov/pubmed/30875744 http://dx.doi.org/10.3390/jof5010023

Ejemplares similares

What Is New in Pulmonary Mucormycosis?
por: Danion, François, et al.
Publicado: (2023)

Recent advances in the understanding and management of mucormycosis
por: Pilmis, Benoit, et al.
Publicado: (2018)

Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis
por: Serris, Alexandra, et al.
Publicado: (2022)

Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication
por: Danion, François, et al.
Publicado: (2021)

Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006
por: Bitar, Dounia, et al.
Publicado: (2009)

An ubiquitous entity of post-COVID rhinomaxillary mucormycosis
por: Dhara, Vasantha, et al.
Publicado: (2022)

The Input of Structural Vaccinology in the Search for Vaccines against Bunyaviruses
por: Serris, Alexandra
Publicado: (2021)

Posttraumatic Mucormycosis: A Nationwide Study in France and Review of the Literature
por: Lelievre, Lucie, et al.
Publicado: (2014)

Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report
por: Cornu, Marjorie, et al.
Publicado: (2018)

Case Report and Literature Review of Prosthetic Cardiovascular Mucormycosis
por: Hoellinger, Baptiste, et al.
Publicado: (2023)

Tumor shape pulmonary mucormycosis associated with sinonasal aspergillosis in a diabetic patient
por: Point, Sophie, et al.
Publicado: (2017)

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
por: Hoenigl, Martin, et al.
Publicado: (2022)

P397 Influence of underlying conditions on disease presentation and diagnostic strategy during pulmonary mucormycosis: Anational study of 114 cases
por: Coste, Anne, et al.
Publicado: (2022)

An Emergent Entity: Indolent Mucormycosis of the Paranasal Sinuses. A Multicenter Study
por: Celis-Aguilar, Erika, et al.
Publicado: (2019)

Mucormycosis: A rare entity with rising clinical presentation in immunocompromised hosts
por: Pandilwar, P.K., et al.
Publicado: (2020)

A rare entity to major outbreak: a case report on mucormycosis
por: Gupta, Dhaman, et al.
Publicado: (2021)

Endobronchial mucormycosis: A rare clinical entity diagnosed by endobronchial cryobiopsy
por: Bajwa, Awais, et al.
Publicado: (2022)

COVID-19-Associated Pulmonary Mucormycosis: An Underdiagnosed Entity with High Mortality
por: Muthu, Valliappan, et al.
Publicado: (2022)

Therapy of Mucormycosis
por: Sipsas, Nikolaos V., et al.
Publicado: (2018)

Global Epidemiology of Mucormycosis
por: Prakash, Hariprasath, et al.
Publicado: (2019)

Mucormycosis in Burn Patients
por: Devauchelle, Pauline, et al.
Publicado: (2019)

Epidemiology of Mucormycosis in India
por: Prakash, Hariprasath, et al.
Publicado: (2021)

Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
por: Chavarot, Nathalie, et al.
Publicado: (2021)

Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
por: García-Carnero, Laura C., et al.
Publicado: (2022)

Aspergillus fumigatus Infection in Humans With STAT3-Deficiency Is Associated With Defective Interferon-Gamma and Th17 Responses
por: Danion, François, et al.
Publicado: (2020)

Resolving the equation between mucormycosis and COVID-19 disease
por: Pasrija, Ritu, et al.
Publicado: (2022)

Mucormycosis: The Scathing Invader
por: Vasudevan, Biju, et al.
Publicado: (2021)

Animal Models to Study Mucormycosis
por: Jacobsen, Ilse D.
Publicado: (2019)

Molecular Strategies to Diagnose Mucormycosis
por: Millon, Laurence, et al.
Publicado: (2019)

Mucormycosis of the Central Nervous System
por: Chikley, Amanda, et al.
Publicado: (2019)

Epidemiology and Diagnosis of Mucormycosis: An Update
por: Skiada, Anna, et al.
Publicado: (2020)

Recent Developments in the Diagnosis of Mucormycosis
por: Dannaoui, Eric
Publicado: (2022)

Pulmonary Mucormycosis: An Interesting Case of Rhizopus Mucormycosis
por: Ukoha, Chijioke D, et al.
Publicado: (2021)

COVID-19-Associated Pulmonary Mucormycosis
por: Krishna, Vidya, et al.
Publicado: (2022)

Gastrointestinal Mucormycosis: A Clinical Review
por: Addasi, Yazan, et al.
Publicado: (2023)

Severe Dermatophytosis and Acquired or Innate Immunodeficiency: A Review
por: Rouzaud, Claire, et al.
Publicado: (2015)

Cryptococcus gattii in Patients with Lymphoid Neoplasms: An Illustration of Evolutive Host–Fungus Interactions
por: Paccoud, Olivier, et al.
Publicado: (2021)

The polyG diseases: a new disease entity
por: Liufu, Tongling, et al.
Publicado: (2022)

S4.1d In vitro activity of eight antifungals against 3343 filamentous pathogenic fungi collected during 18 years at the French National Reference Center for invasive mycosis and antifungals
por: Garcia-Hermoso, Dea, et al.
Publicado: (2022)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
por: Donnelley, Monica A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bfo5endcii19v30sbrkjssiq17